Search results for "Osteoclast"

showing 10 items of 77 documents

Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review

2015

Introduction: Orthodontic anchorage is one of the most challenging aspects of Orthodontics. Preventing undesired movement of teeth could result in safer and less complicated orthodontic treatment. Recently, several reviews have been published about the effects of different molecules on bone physiology and the clinical side effects in Orthodontics. However, the effects of local application of these substances on the rate of orthodontic tooth movement have not been assessed.Objectives: The aim of this research was to analyze the scientific evidence published in the literature about the effects of different molecules on orthodontic anchorage.Methods: The literature was systematically reviewed …

Bone remodeling periodBisfosfonatosTooth Movement TechniquesMovimentação dentáriaPharmacological managementAnti-Inflammatory AgentsOsteoclastsPamidronateDentistryZoledronic AcidAntioxidantsLactonesMiceStilbenesOrthodontic Anchorage ProceduresMedicineAgentes anti-inflamatóriosSulfonesAnti-inflammatory agentsOrthodonticsDiphosphonatesOsteoprotegerinaImidazolesOrthodontic anchorage proceduresArticlesBisphosphonatesProcedimentos de ancoragem ortodônticaTooth movementInclusion and exclusion criteriaBone RemodelingTooth MobilityOral SurgeryDiclofenacMEDLINEOrthodonticsKappa indexInterferon-gammaAnimalsHumansbusiness.industryOsteoprotegerinBone physiologyIsoxazolesOrthodontic Anchorage ProceduresAcetylcysteineRatslcsh:RK1-715CelecoxibResveratrolTooth movementlcsh:DentistryClodronic Acidbusiness
researchProduct

IL GRANULOMA CENTRALE A CELLULE GIGANTI DEI MASCELLARI

2009

Central giant cell granuloma ( CGCG ), is a fibro-osseous lesion. The majority of lesions are observed in the mandible and mainly in children and young adults, more often in females than in males. This lesion, which the pathogenesis still remains obscure, appears as radiolucency, well or ill-defined, uni or multilocular with trabeculations coursing through the lesion. Histologic study shows giant cells, fibroblastic cells, and foci of hemorrhage and osteoid tissue. On the basis of clinical, radiological and histologic features, central giant cell granulomas can be classified as "non-aggressive" or "aggressive"; the histomorphometric analysis prove a significant increase in large giant cells…

CGCG ossa mascellari osteoclasta KB(RANK)Settore MED/28 - Malattie Odontostomatologiche
researchProduct

PO-146 Multiple myeloma-derived exosomes carry amphiregulin and are responsible for the uncoupled bone remodelling

2018

Introduction Multiple myeloma (MM) is a hematologic malignancy associated with osteolytic bone disease caused by the perturbation of the functional balance between bone resorption and bone formation. Exosomes, nanosize lipoproteic structures, have been recently recognised as a new mechanism of cell to cell communication during tumour growth and progression. We have previously shown that MM-exosomes are involved in osteolytic lesions but the underlying mechanism is still understood. We hypothesise that the epidermal growth factor receptor ligand Amphiregulin (AREG) can be delivered by multiple myeloma-derived exosomes and participate in modulating the response of the bone microenvironment to…

Cancer ResearchChemistryMesenchymal stem cellExosomeBone resorptionMicrovesiclesBone remodelingmedicine.anatomical_structureOncologyAmphiregulinCell cultureOsteoclastmedicineCancer researchESMO Open
researchProduct

Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases.

2009

The immunogenic properties of renal cell carcinoma (RCC) on bone osteolysis were investigated. mRNA expression of three proinflammatory cytokines, monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6) and interleukin-8 (IL-8), were determined in a panel of RCC lines (CRBM 1990, ACHN and Caki-1). Moreover proinflammatory cytokine mRNA expression and protein levels of adhesion molecules, intercellular adhesion molecule-1 (ICAM-1) and E-selectin, on human umbilical vein endothelial cells (HUVEC) incubated with the conditioned media from RCC lines were evaluated. RCC express mRNA of MCP-1, IL-6 and IL-8 that may induce a proinflammatory phenotype in endothelial cells. mRNA expression of …

Cancer ResearchPathologymedicine.medical_specialtyOsteolysisVascular Cell Adhesion Molecule-1Bone NeoplasmsOsteolysisBiologyurologic and male genital diseasesModels BiologicalProinflammatory cytokineOsteoclastmedicineHumansCarcinoma Renal CellCells CulturedCell adhesion moleculeMonocyteBone metastasisEndothelial Cellsmedicine.diseaseIntercellular Adhesion Molecule-1Kidney NeoplasmsEndothelial stem cellmedicine.anatomical_structureOncologyGene Expression RegulationCulture Media ConditionedCancer researchCytokinesCytokine secretionInflammation MediatorsE-SelectinInternational journal of oncology
researchProduct

Bone damage after chemotherapy for lymphoma: a real-world experience

2021

AbstractBackgroundDespite recent improvements in survival due to advances in treatment, the quality of life of patients with lymphoma may be compromised by the long-term complications of chemotherapy and steroid therapy. Among these, a potentially relevant problem is bone loss and the development of fragility fractures.AimTo provide further evidence of clinical or subclinical skeletal complications in correlation with biological variables and markers of bone disease in patients with complete response to therapy.MethodA cross-sectional observational study was conducted on subjects diagnosed with lymphoma with subsequent antineoplastic treatment, disease status after therapy defined as comple…

Chemotherapy Osteoporosis Lymphoma Steroids Bone losses OsteoclasticLymphomaBone lossesResearchOsteoclasticDiseases of the musculoskeletal systemVitamin D DeficiencyCross-Sectional StudiesRC925-935RheumatologyBone DensityQuality of LifeBone losses; Chemotherapy; Lymphoma; Osteoclastic; Osteoporosis; Steroids; Aged; Bone Density; Cross-Sectional Studies; Humans; Quality of Life; Lymphoma; Osteoporosis; Vitamin D DeficiencyHumansOsteoporosisChemotherapySteroidsOrthopedics and Sports MedicineAgedBMC Musculoskeletal Disorders
researchProduct

Terpenoid treatment in osteoporosis: this is where we have come in research.

2021

Lower bone resistance to load is due to the imbalance of bone homeostasis, where excessive bone resorption, compared with bone formation, determines a progressive osteopenia, leading to a high risk of fractures and consequent pain and functional limitations. Terpenoids, with their activities against bone resorption, have recently received increased attention from researchers. They are potentially more suitable for long-term use compared with traditional therapeutics. In this review of the literature of the past 5 years, we provide comprehensive information on terpenoids, with their anti-osteoporotic effects, highlighting molecular mechanisms that are often in epigenetic key and a possible p…

Endocrinology Diabetes and MetabolismOsteoporosisBioinformaticsBone resorptionBone and BonesFractures BoneEndocrinologyOsteoclastterpenoidsSettore BIO/13 - Biologia ApplicataSettore BIO/10 - Biochimicamedicinebone erosive diseasesHumansBone formationBone ResorptionProgressive osteopeniaepigeneticsbusiness.industryTerpenesOsteoporosis preventionOsteoblastmedicine.diseaseSettore BIO/18 - Geneticamedicine.anatomical_structureosteoclastosteoblastOsteoporosisbusinessTrends in endocrinology and metabolism: TEM
researchProduct

Non-flavonoid polyphenols in osteoporosis: preclinical evidence

2021

The development of progressive osteopenia and osteoporosis (OP) is due to the imbalance between bone resorption and bone formation, determining a lower bone resistance, major risks of fractures, with consequent pain and functional limitations. Flavonoids, a class of polyphenols, have been extensively studied for their therapeutic activities against bone resorption, but less attention has been given to a whole series of molecules belonging to the polyphenolic compounds. However, these classes have begun to be studied for the treatment of OP. In this systematic review, comprehensive information is provided on non-flavonoid polyphenolic compounds, and we highlight pathways implicated in the ac…

Endocrinology Diabetes and MetabolismOsteoporosisFlavonoid030209 endocrinology & metabolismBioinformaticsBone resorption03 medical and health sciences0302 clinical medicineEndocrinologypolyphenolic compoundsSettore BIO/13 - Biologia ApplicataOsteogenesisSettore BIO/10 - Biochimicabone erosive diseasesHumansMedicineBone formationBone ResorptionProgressive osteopeniaFlavonoidschemistry.chemical_classificationepigeneticsbusiness.industryPolyphenolsfood and beveragesmedicine.diseaseSettore BIO/18 - GeneticachemistryPolyphenolosteoclastosteoblastOsteoporosisbusinessTrends in Endocrinology & Metabolism
researchProduct

Flavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment

2020

Imbalance of bone homeostasis, with excessive bone resorption compared with bone formation, leads to the development of progressive osteopenia leading to lower bone resistance to load, with consequent pain and functional limitations. Phytochemicals with therapeutic and preventive effects against bone resorption have recently received increasing attention since they are potentially more suitable for long-term use than traditional therapeutic chemical compounds. In this systematic review of the literature of the past 5 years, comprehensive information is provided on flavonoids with potential antiresorption and pro-osteogenic effects. It aims to highlight the molecular mechanisms of these mole…

Endocrinology Diabetes and MetabolismOsteoporosisOsteoclasts030209 endocrinology & metabolismBioinformaticsBone resorption03 medical and health sciences0302 clinical medicineEndocrinologyOsteoclastSettore BIO/13 - Biologia ApplicataSettore BIO/10 - BiochimicaOsteoporosis treatmentbone erosive diseasesMedicineAnimalsHumansEpigeneticsProgressive osteopeniaOsteoblastsbusiness.industrySettore BIO/16 - Anatomia UmanaOsteoblastmedicine.diseaseosteoporosisSettore BIO/18 - Geneticamedicine.anatomical_structureflavonoidsosteoclastosteoblastbusinessHomeostasisepigenetic
researchProduct

Effects of exosomes released by NSCLC cells on osteoclasts differentiation in ISTITUTO SUPERIORE DI SANITA’, ROMA AICC

2016

Exosomes EGFR osteoclasts lung cancer
researchProduct

TRAP-Positive Multinucleated Giant Cells Are Foreign Body Giant Cells Rather Than Osteoclasts: Results From a Split-Mouth Study in Humans

2014

This study compared the material-specific tissue response to the synthetic, hydroxyapatite-based bone substitute material NanoBone (NB) with that of the xenogeneic, bovine-based bone substitute material Bio-Oss (BO). The sinus cavities of 14 human patients were augmented with NB and BO in a split-mouth design. Six months after augmentation, bone biopsies were extracted for histological and histomorphometric investigation prior to dental implant insertion. The following were evaluated: the cellular inflammatory pattern, the induction of multinucleated giant cells, vascularization, the relative amounts of newly formed bone, connective tissue, and the remaining bone substitute material. NB gra…

Giant Cells Foreign-BodyMouthPathologymedicine.medical_specialtyForeign-body giant cellBone substituteChemistryOsteoclastsAnatomyGiant CellsGiant cellBone SubstitutesBone cellmedicineAnimalsHumansCattleOral SurgeryJournal of Oral Implantology
researchProduct